Julian Adams

2015

In 2015, Julian Adams earned a total compensation of $1.8M as President of R&D at Infinity Pharmaceuticals, a 54% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$87,150
Option Awards$1,233,275
Salary$497,289
Other$2,879
Total$1,820,593

Adams received $1.2M in option awards, accounting for 68% of the total pay in 2015.

Adams also received $87.2K in non-equity incentive plan, $497.3K in salary and $2.9K in other compensation.

Rankings

In 2015, Julian Adams' compensation ranked 5,110th out of 13,638 executives tracked by ExecPay. In other words, Adams earned more than 62.5% of executives.

ClassificationRankingPercentile
All
5,110
out of 13,638
63rd
Division
Manufacturing
1,887
out of 5,190
64th
Major group
Chemicals And Allied Products
681
out of 1,854
63rd
Industry group
Drugs
541
out of 1,528
65th
Industry
Pharmaceutical Preparations
426
out of 1,182
64th
Source: SEC filing on April 25, 2016.

Adams' colleagues

We found five more compensation records of executives who worked with Julian Adams at Infinity Pharmaceuticals in 2015.

2015

Adelene Perkins

Infinity Pharmaceuticals

Chief Executive Officer

2015

Sujay Kango

Infinity Pharmaceuticals

Chief Commercial Officer

2015

Lawrence Bloch

Infinity Pharmaceuticals

Chief Financial Officer

2015

David Roth

Infinity Pharmaceuticals

Chief Medical Officer

2015

Vito Palombella

Infinity Pharmaceuticals

Chief Scientific Officer

In-depth

You may also like